ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

DYN Dyne Therapeutics Inc

31.25
-0.28 (-0.89%)
After Hours
Last Updated: 15:00:42
Delayed by 15 minutes

Period:

Draw Mode:

Volume 2,640,424
Bid Price 30.20
Ask Price 31.86
News (1)
Day High 32.0599

Low
6.40

52 Week Range

High
35.98

Day Low 30.93
Share Name Share Symbol Market Stock Type
Dyne Therapeutics Inc DYN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.28 -0.89% 31.25 15:00:42
Open Price Low Price High Price Close Price Previous Close
31.95 30.93 32.0599 31.25 31.53
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
21,702 2,640,424 US$ 31.56 US$ 83,336,967 - 6.40 - 35.98
Last Trade Type Quantity Price Currency
15:54:57 formt 10,530 US$ 31.25 USD

Dyne Therapeutics (DYN) Options Flow Summary

Overall Flow

Bullish

Net Premium

407k

Calls / Puts

100.00%

Buys / Sells

0.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

Dyne Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.57B 81.96M - 0 -235.94M -2.88 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Dyne Therapeutics News

Date Time Source News Article
5/22/202420:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/22/202415:30Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
5/22/202406:59Edgar (US Regulatory)Form 8-K - Current report
5/21/202419:39GlobeNewswire Inc.Dyne Therapeutics Announces Pricing of $325.5 Million Public..
5/20/202417:00Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
5/20/202415:24Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
5/20/202415:01GlobeNewswire Inc.Dyne Therapeutics Announces Proposed Public Offering of..
5/20/202406:37Edgar (US Regulatory)Form 8-K - Current report
5/20/202405:30GlobeNewswire Inc.Dyne Therapeutics Announces New Clinical Data from ACHIEVE..
5/19/202407:00GlobeNewswire Inc.Dyne Therapeutics to Host Virtual Investor Event to Review..
5/17/202420:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/17/202420:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No DYN Message Board. Create One! See More Posts on DYN Message Board See More Message Board Posts

Historical DYN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week27.2335.9827.0432.283,199,4054.0214.76%
1 Month24.9035.9823.1629.751,366,5796.3525.50%
3 Months25.6635.9823.1127.811,407,0795.5921.78%
6 Months10.5335.9810.1221.861,623,37520.72196.77%
1 Year13.9135.986.4018.881,071,52817.34124.66%
3 Years18.0835.984.3016.84529,34213.1772.84%
5 Years23.4535.984.3017.15493,1997.8033.26%

Dyne Therapeutics Description

Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy.